3 studies found for:    20071701 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Dipeptidyl Peptidase-4 Inhibition and Narrow-band Ultraviolet-B Light in Psoriasis (DINUP)
Condition: Psoriasis
Intervention: Drug: Sitagliptin (Januvia)
2 Active, not recruiting Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
Conditions: Psoriasis;   Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin;   Drug: Gliclazide;   Drug: Sitagliptin matched placebo;   Drug: Gliclazide matched placebo capsule
3 Completed
Has Results
An Efficacy and Safety Study of CNTO 1275 Compared to Etanercept in Patients With Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: CNTO 1275 45 mg;   Drug: CNTO 1275 90 mg;   Drug: Etanercept 50 mg

Indicates status has not been verified in more than two years